anidulafungin has been researched along with AIDS-Related Opportunistic Infections in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, HC; Chen, TC; Yang, WT | 1 |
| Clark, K; Fichtenbaum, C; Goldstein, BP; Reboli, A; Schranz, JA; Vazquez, JA | 1 |
| De Bellis, P | 1 |
| Bernal, S; Chávez, M; Gutierrez, MJ; Mazuelos, EM; Quindós, G; Valverde, A | 1 |
1 trial(s) available for anidulafungin and AIDS-Related Opportunistic Infections
| Article | Year |
|---|---|
A phase 2, open-label study of the safety and efficacy of intravenous anidulafungin as a treatment for azole-refractory mucosal candidiasis.
Topics: Adult; AIDS-Related Opportunistic Infections; Anidulafungin; Antifungal Agents; Azoles; Candidiasis; Candidiasis, Oral; Drug Resistance, Fungal; Echinocandins; Esophageal Diseases; Female; Humans; Male; Middle Aged; Mucous Membrane | 2008 |
3 other study(ies) available for anidulafungin and AIDS-Related Opportunistic Infections
| Article | Year |
|---|---|
Pneumocystis jirovecii pneumonia in a human immunodeficiency virus-infected patient with G6PD deficiency-successful treatment with anidulafungin.
Topics: AIDS-Related Opportunistic Infections; Anidulafungin; Antifungal Agents; Antiretroviral Therapy, Highly Active; Glucosephosphate Dehydrogenase Deficiency; HIV Infections; Humans; Immunocompromised Host; Male; Pneumonia, Pneumocystis; Treatment Outcome; Young Adult | 2018 |
Conclusions. Anidulafungin is a new echinocandin developed for more effective treatment of serious systemic fungal infections.
Topics: AIDS-Related Opportunistic Infections; Anidulafungin; Antifungal Agents; Candidiasis; Cross Infection; Echinocandins; Humans | 2009 |
In-vitro activity of voriconazole (UK-109,496), LY303366 and other antifungal agents against oral Candida spp. isolates from HIV-infected patients.
Topics: AIDS-Related Opportunistic Infections; Anidulafungin; Antifungal Agents; Candida; Candidiasis, Oral; Echinocandins; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 1999 |